KR20170100245A - Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients - Google Patents
Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients Download PDFInfo
- Publication number
- KR20170100245A KR20170100245A KR1020160022558A KR20160022558A KR20170100245A KR 20170100245 A KR20170100245 A KR 20170100245A KR 1020160022558 A KR1020160022558 A KR 1020160022558A KR 20160022558 A KR20160022558 A KR 20160022558A KR 20170100245 A KR20170100245 A KR 20170100245A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- atopic dermatitis
- skin
- cosmetic composition
- tree
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000284 extract Substances 0.000 title claims abstract description 75
- 239000000203 mixture Substances 0.000 title claims abstract description 68
- 206010012438 Dermatitis atopic Diseases 0.000 title claims abstract description 48
- 201000008937 atopic dermatitis Diseases 0.000 title claims abstract description 48
- 239000002537 cosmetic Substances 0.000 title claims abstract description 29
- 239000004480 active ingredient Substances 0.000 title claims abstract description 13
- 241000723436 Chamaecyparis obtusa Species 0.000 title claims abstract description 10
- 241000392544 Dendropanax morbifer Species 0.000 title claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000002360 preparation method Methods 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 14
- 239000006071 cream Substances 0.000 claims description 10
- 230000006872 improvement Effects 0.000 claims description 10
- 239000000839 emulsion Substances 0.000 claims description 9
- 239000006210 lotion Substances 0.000 claims description 8
- 230000002265 prevention Effects 0.000 claims description 6
- 239000000499 gel Substances 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 4
- 230000008020 evaporation Effects 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000000725 suspension Substances 0.000 claims description 4
- 239000006072 paste Substances 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 2
- 240000005109 Cryptomeria japonica Species 0.000 claims 1
- 241000261585 Hadrobregmus pertinax Species 0.000 claims 1
- 241000209140 Triticum Species 0.000 claims 1
- 235000021307 Triticum Nutrition 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000002023 wood Substances 0.000 abstract description 19
- 238000011282 treatment Methods 0.000 abstract description 8
- -1 phenol compound Chemical class 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 14
- 238000000605 extraction Methods 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000002253 acid Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 239000000469 ethanolic extract Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 208000003251 Pruritus Diseases 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 230000001684 chronic effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229960001631 carbomer Drugs 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 229940082500 cetostearyl alcohol Drugs 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 229940119170 jojoba wax Drugs 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000008591 skin barrier function Effects 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 2
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000003296 Petasites japonicus Species 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 244000018795 Prunus mume Species 0.000 description 2
- 235000011158 Prunus mume Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 244000204900 Talipariti tiliaceum Species 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000001256 steam distillation Methods 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000036572 transepidermal water loss Effects 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000192043 Echinochloa Species 0.000 description 1
- 235000009414 Elaeocarpus kirtonii Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 240000004929 Juglans cinerea Species 0.000 description 1
- 235000014056 Juglans cinerea Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 244000088461 Panicum crus-galli Species 0.000 description 1
- 235000011999 Panicum crusgalli Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000238711 Pyroglyphidae Species 0.000 description 1
- 244000274906 Quercus alba Species 0.000 description 1
- 235000009137 Quercus alba Nutrition 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010053262 Skin swelling Diseases 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000236151 Tabebuia pallida Species 0.000 description 1
- 235000013584 Tabebuia pallida Nutrition 0.000 description 1
- 241001532014 Xanthorrhoea Species 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229960004784 allergens Drugs 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 239000003693 atypical antipsychotic agent Substances 0.000 description 1
- 229940127236 atypical antipsychotics Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008341 cosmetic lotion Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 229940046533 house dust mites Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000037370 skin discoloration Effects 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000009192 ultraviolet light therapy Methods 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
편백나무(Chamaecyparis obtusa) 추출물 및 황칠나무(Dendropanax morbifera) 수증기 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 화장료 조성물에 관한 것으로, 상기 화장료 조성물은 아토피 환자를 대상으로한 피부 도포실험에서 유의적인 아토피 피부염 개선효과를 나타내므로, 상기 편백나무 수증기 추출물 및 황백나무 수증기 추출물은 아토피 피부염 개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있다.The present invention relates to a cosmetic composition for improving atopic dermatitis containing an extract of Chamaecyparis obtusa and a water vapor extract of Dendropanax morbifera as an active ingredient. The cosmetic composition is useful for the treatment of atopic dermatitis Therefore, the water extract of Wako wood and the water vapor extract of Wako white can be effectively used as an active ingredient of a cosmetic composition for improving atopic dermatitis.
Description
본 발명은 편백나무(Chamaecyparis obtusa) 추출물 및 황칠나무(Dendropanax morbifera) 수증기 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 화장료 조성물, 및 피부 외용제에 관한 것이다.
The present invention relates to a cosmetic composition for improving atopic dermatitis containing Chamaecyparis obtusa extract and water extract of Dendropanax morbifera as an active ingredient, and a dermatological external preparation.
아토피 피부염(atopic dermatitis)은 만성적이며 재발이 빈번한 염증성 피부질환이다. 피부건조증과 소양증, 이로 인해 긁게 되면 습진 및 염증성 피부병변이 생기며 이것이 진행되면서 더 심한 소양증 및 수면장애 등이 유발되는 악순환이 반복된다. 또한 초기에 적절한 관리를 하지 않으면 삼출과 가피를 동반한 홍반성의 박탈성 구진과 인설로 진행되기도 하고 피부가 두꺼워지고 주름이 지는 태선화(苔癬化, lichenification) 등으로 진행되기도 한다. 유아기에는 보통 목과 팔다리, 무릎 뒤 등의 굽혀지는 쪽 부분에 습진 형태로 나타나고 만성화 되면 습진 부위 피부가 태선화가 나타나고, 성인기까지 아토피 피부염이 남는 경우에는 특정 물질이나 자극에 의해 쉽게 염증 반응에 노출되는 경향이 많고, 몸보다는 얼굴 주변이나 사지말단에 습진이 생기거나 홍반 및 홍조가 나타나는 경향이 있다.Atopic dermatitis is a chronic, recurrent inflammatory skin disease. Skin dryness and pruritus, resulting in scratching, eczema and inflammatory skin lesions, and as it progresses, more severe pruritus and sleep disorders are caused by a vicious cycle is repeated. In addition, if not properly managed at the initial stage, it may progress to disseminated papules and erythema with erythema and exudate, followed by thickening and wrinkling of the skin and lichenification. In infancy, eczema usually appears on the bent part of the neck, limbs, and back of the knee. When chronic, the skin of the eczema appears to be fizzy, and when atopic dermatitis remains until adulthood, it tends to be easily exposed to the inflammatory reaction by specific substances or stimuli And there is a tendency to develop eczema or erythema and flushing around the face or limb rather than the body.
아토피 피부염은 유전 및 환경적 요인의 상호작용으로 인한 복합적 임상 증상으로 다양하게 나타나기 때문에 발병 원인이 어느 한 가지로만 설명될 수는 없으나, 매연 등의 환경 공해, 식품첨가물 등의 사용 증가, 실내 온도 상승으로 인한 집먼지 진드기 등의 알레르기를 일으키는 원인 물질(알레르겐)의 증가 등 환경적인 요인과 유전적인 소인, 면역학적 반응 및 피부보호막의 이상, 가족력(유전적인 영향) 등이 주요 원인으로 여겨지고 있다.Atopic dermatitis is a complex clinical manifestation due to the interaction of hereditary and environmental factors. Therefore, the cause of the disease can not be explained by any one reason. However, the environmental pollution such as soot, increase of use of food additives, (Allergens) caused by allergies such as house dust mites due to the environmental factors, genetic predisposition, immunological response, skin barrier and family history (genetic influence) is considered to be the main cause.
황색포도상구균(Staphylococcus aureus)은 사람이나 동물의 피부표면에 생육하면서 화농성 염증 질환을 일으킬 뿐 아니라 아토피 피부염을 일으키는 주범이기도 하다. 아토피 피부염 환자의 대부분의 병변에서 황색포도상구균이 고밀도로 발견되어 황색포도상구균이 아토피 피부염의 악화를 가중시킨다고 한다. 실제로 황색포도상구균의 외독소가 확인된 환자들의 SCORAD 점수가 다른 이들 보다 높을 뿐 아니라, 피부건조증, 태선화, 지지간 미란 등의 진행을 가속시킨다. Staphylococcus aureus is a major cause of atopic dermatitis as well as causing pyogenic inflammatory disease by growing on the skin surface of humans and animals. Staphylococcus aureus is found at high density in most lesions of patients with atopic dermatitis, and Staphylococcus aureus aggravates the deterioration of atopic dermatitis. In fact, the SCORAD score of patients with externally identified Staphylococcus aureus is higher than the others, and accelerates the progression of dry skin, psoriasis, and interstitial erosion.
종합적으로 아토피 피부염 환자는 피부장벽의 이상이 있어, 피부수분보유량이 감소하며, 피부의 pH 수치의 증가 및 경피수분증발량이 증가할 뿐 아니라, 아토피 피부염 병변에서 황색 포도상구균의 집락수가 정상인에 비해 월등히 높다.
In general, atopic dermatitis patients have abnormalities of skin barrier, decrease of skin moisture content, increase of skin pH value and increase of transdermal water evaporation, as well as colonization of Staphylococcus aureus in atopic dermatitis lesions high.
현재 아토피 피부염 환자의 임상 점수인 SCORAD(Scoring of Atopic Dermatitis), ADSI(Atopic Dermatitis Severity Index) 등으로 아토피 피부염의 중증도를 평가하며, 피부에 직접 기계장비를 이용하여 항온, 항습 등 일정한 조건하에서의 피부수분보유량(skin surface hydration, SSH), 피부의 pH, 경피수분증발량(transepidermal water loss, TEWL) 등을 측정함으로써 피부의 장벽 기능과 염증 상태 등의 피부손상지표를 객관적으로 평가한다.Currently, the severity of atopic dermatitis is assessed by SCORAD (Scoring of Atopic Dermatitis) and ADSI (Atopic Dermatitis Severity Index), which are clinical scores of patients with atopic dermatitis. Objectively assess skin damage indicators such as skin barrier function and inflammation status by measuring skin surface hydration (SSH), skin pH, and transepidermal water loss (TEWL).
아토피 피부염의 기본적인 치료로 피부의 청결과 건조 방지를 위해 보습제의 사용, 피부염증을 완화시키기 위해 경구용 항히스타민제, 스테로이드제, 면역억제제, 항생제, 항바이러스제, 항진균제, 생균제 등의 치료제제의 사용 및 광화학요법(psoralens and ultraviolet light therapy, PUVA) 등 무수히 많은 치료 요법을 사용하고 있으나, 이러한 제제를 장기간 사용 시 피부 위축 및 팽창, 혈관 및 모공 확장, 피부 변색 등의 부작용이 유발될 뿐 아니라, 아토피 피부염의 특성상 만성적이거나 재발을 자주하면서 질환에 대한 회의와 스테로이드제와 같은 약물의 부작용에 대한 우려도 커 제대로 된 치료가 이루어지지 못하거나, 검증되지 않은 치료 방법에 의존하여 결국 악화와 호전을 반복하는 만성질환이 되는 경우도 많다. 따라서, 부작용이 없고 인체에 안전한 천연물 유래 아토피 피부염 치료제가 꾸준히 요구되고 있는 실정이다.
The basic treatment of atopic dermatitis is the use of a moisturizing agent to prevent skin's cleansing and drying, the use of oral antihistamines, steroids, immunosuppressants, antibiotics, antivirals, antifungals, Although many treatments such as psoralens and ultraviolet light therapy (PUVA) are used, prolonged use of these agents not only causes side effects such as skin atrophy and swelling, enlargement of blood vessels and pores, skin discoloration, , It is chronic or recurring frequently, and there are concerns about the side effects of drugs such as steroids and meetings with the disease, which may result in failure to provide proper treatment, or chronic therapy that relies on unproven treatment methods, There are many cases of disease. Therefore, there is a constant demand for a therapeutic agent for atopic dermatitis derived from natural materials which is free from side effects and safe to human body.
편백나무(Chamaecyparis obtusa)는 노송나무라고도 하며, 겉씨식물 구과목 측백나무과의 상록교목으로서, 일본이 원산지이지만 개발을 통해 우리나라 남부 지방에서 조림수종으로 널리 재배되고 있는데, 편백나무 특유의 향으로 인해 탈취제, 항균제 등으로 사용되고 있다. Chamaecyparis obtusa , also known as cypress tree, is an evergreen tree of the ginseng plant, a plant species, and is widely cultivated as a planting species in the southern part of Korea through development, although it is originated in Japan. , Antibacterial agents and the like.
편백나무에서 생산되는 피톤치드는 식물의 자기방어물질로써, 병원균 및 해충, 곰팡이 등에 저항하기 위해 식물이 내뿜거나 분비하는 물질로 그 자체에 살균, 살충성분이 포함되어 있다. 피톤치드의 구성물질은 테르펜을 비롯한 페놀 화합물, 알칼로이드 성분, 글리코시드 등으로 이루어진 유기화합물이며, 항균작용, 진정작용, 탈취작용, 스트레스 해소작용 등을 하는 것으로 알려져 있다. 이러한 피톤치드는 화학합성 물질이 아닌 천연물질이고, 인간의 신체에 무리 없이 흡수되며, 인간에게 해로운 균들을 선택적으로 살균한다. 따라서 편백나무의 활용하는 다양한 연구가 진행되고 있는 실정이다.
Phytoncide is a self-defense substance of plants. It is a substance that plants excrete or secretes to resist pathogens, insects and fungi, and contains sterilization and insecticides. The constituent material of phytoncide is an organic compound composed of a phenol compound such as terpene, an alkaloid component, a glycoside, etc., and is known to have antimicrobial action, sedative action, deodorizing action and stress relieving action. Such phytoncide is a natural substance, not a chemical synthetic substance, and selectively absorbs bacteria which are absorbed in human body and harmful to human being. Therefore, various researches are being carried out to utilize the white wood.
황칠나무(Dendropanax morbifera)는 두릅나무과(Araliaceae)에 속하는 상록활엽수림이며, 전남 서남해안 및 도서지방에서만 자생 및 재배되는 난대성 수종이다. 황칠의 수지는 황금색이고 내열, 내구, 내수성이 강하며 부착성 및 광택이 좋아 예로부터 전통공예품에 천연도료 및 민간 의약품 소재로 쓰여지고 있다. 또한 황칠은 세스퀴테르펜 등의 정유 성분 뿐만 아니라, 아라키딕산, 팔미틱산, 아르기닌 등 다양한 성분을 함유하고 있으며, 동맥경화, 간기능 개선, 항산화, 뼈 재생 촉진, 면역 증강, 항균, 항암 등의 효과를 갖는 것으로 알려져 있으나, 아토피 피부염에 대한 효과에 대해서는 알려진 바 없다.
Dendropanax morbifera is an evergreen broad-leaved forest belonging to Araliaceae. It is an endemic species grown and cultivated only in the western and southern coastal regions of Chonnam Province. Huangchil resin is golden color, strong in heat resistance, durability, water resistance, good adhesion and gloss, and has been used as a natural paints and civilian medicine materials in traditional handicrafts since ancient times. In addition, Huangchil contains various components such as arachidonic acid, palmitic acid, and arginine as well as essential oil components such as sesquiterpene, and is effective for atherosclerosis, liver function improvement, antioxidation, bone regeneration promotion, immunity enhancement, However, the effect on atopic dermatitis is not known.
이에, 본 발명자들은 인체에 안전하고 부작용이 없으며, 현저한 아토피 피부염 개선 효과를 갖는 화장료 조성물을 개발하기 위해 노력한 결과, 편백나무 수증기 추출물 및 황칠나무 수증기 추출물이 아토피 환자를 대상으로한 피부 도포실험에서 유의적인 아토피 피부염 개선효과를 나타냄을 확인함으로써, 아토피 피부염 개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있음을 밝힘으로써, 본 발명을 완성하였다.
Accordingly, the present inventors have made efforts to develop a cosmetic composition having a safe and adverse effect on the human body and having a remarkable effect of improving atopic dermatitis. As a result, it has been found that the water vapor extract of Huaxia tree and the water vapor extract of Huaxia wood are effective in skin application tests for atopic patients The present invention has been accomplished on the basis of the findings that it can be effectively used as an effective ingredient of a cosmetic composition for improving atopic dermatitis by confirming that the atopic dermatitis improving effect is exhibited.
본 발명은 목적은 편백나무(Chamaecyparis obtusa) 추출물 및 황칠나무(Dendropanax morbifera) 추출물을 유효성분으로 함유하는 아토피 피부염(atopic dermatitis) 개선용 화장료 조성물, 및 피부 외용제를 제공하기 위한 것이다.
The object of the present invention is to provide a cosmetic composition for improving atopic dermatitis and an external preparation for skin containing Chamaecyparis obtusa extract and Dendropanax morbifera extract as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 편백나무(Chamaecyparis obtusa) 추출물 및 황칠나무(Dendropanax morbifera) 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 화장료 조성물을 제공한다.In order to attain the above object, the present invention provides a cosmetic composition for improving atopic dermatitis, which contains Chamaecyparis obtusa extract and Dendropanax morbifera extract as an active ingredient.
아울러, 본 발명은 편백나무 추출물 및 황칠나무 추출물을 유효성분으로 함유하는 아토피 피부염 예방 및 개선용 피부 외용제를 제공한다.
In addition, the present invention provides an external preparation for skin for prevention and improvement of atopic dermatitis, which contains an extract of Ungermanychus cinnabarstus and a extract of Hwangchujang tree as an active ingredient.
본 발명은 편백나무(Chamaecyparis obtusa) 추출물 및 황칠나무(Dendropanax morbifera) 수증기 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 화장료 조성물에 관한 것으로, 상기 화장료 조성물은 아토피 환자를 대상으로한 피부 도포실험에서 유의적인 아토피 피부염 개선효과를 나타내므로, 상기 편백나무 수증기 추출물 및 황백나무 수증기 추출물은 아토피 피부염 개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있다.
The present invention relates to a cosmetic composition for improving atopic dermatitis containing Chamaecyparis obtusa extract and Dendropanax morbifera water vapor extract as an active ingredient. The cosmetic composition is useful for skin application tests for atopic patients The atypical antipsychotic extract of the present invention can be effectively used as an active ingredient of a cosmetic composition for improving atopic dermatitis.
도 1은 본 발명의 수증기 추출물을 제조하는 방법을 나타낸 도이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a diagram showing a method for producing the steam extract of the present invention. FIG.
이하, 본 발명을 보다 상세히 설명한다.
Hereinafter, the present invention will be described in more detail.
본 발명은 편백나무(Chamaecyparis obtusa) 추출물 및 황칠나무(Dendropanax morbifera) 추출물을 유효성분으로 함유하는 아토피 피부염 개선용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for improving atopic dermatitis containing Chamaecyparis obtusa extract and Dendropanax morbifera extract as an active ingredient.
상기 화장료 조성물은 피부수분보유량을 향상시키고, 피부의 pH를 안정화시키며, 경피수분증발량을 감소시켜 아토피 피부염을 개선시킬 수 있다.The cosmetic composition can improve atopic dermatitis by improving skin moisture retention, stabilizing the pH of the skin, and decreasing the amount of percutaneous water evaporation.
상기 추출물은 하기와 같은 방법으로 제조되는 것이 바람직하나 이에 한정되지 않는다:The extract is preferably prepared by the following method, but is not limited thereto:
1) 편백나무 또는 황칠나무에 추출용매를 가하여 추출하는 단계; 및1) Extracting an extractant from an unplasticized or woody wood; And
2) 단계 1)의 추출물을 여과하는 단계2) filtering the extract of step 1)
본 발명의 제조방법에 있어서, 단계 1)의 편백나무 또는 황칠나무는 재배한 것 또는 시판되는 것을 제한 없이 사용할 수 있다. In the production method of the present invention, the unplasticized or perennial tree of step 1) may be cultivated or commercially available.
상기 편백나무 또는 황칠나무는 1:1의 중량 비율로 혼합한 후 추출용매를 가하여 추출할 수 있고, 편백나무 추출물과 황칠나무 추출물을 각각 제조한 후, 1:1중량 비율로 혼합하여 사용될 수 있다.The whitening wood or the woody wood can be mixed in a weight ratio of 1: 1 and then extracted with an extraction solvent. .
본 발명의 제조방법에 있어서, 상기 단계 1)의 추출용매는 물, 알코올 또는 이의 혼합물을 사용하는 것이 바람직하나, 수증기를 이용하는 것이 가장 바람직하다. 상기 알코올로는 C1 내지 C2의 저급 알코올 이용하는 것이 바람직하다. 추출방법으로는 진탕추출, Soxhelt 추출, 환류 추출 또는 수증기 증류 추출법을 이용하는 것이 바람직하고, 수증기 증류 추출법을 이용하는 것이 가장 바람직하다. 상기 추출용매를 건조된 편백나무 또는 황칠나무 분량의 1 내지 10배 첨가하여 추출하는 것이 바람직하며, 2 내지 3배 첨가하여 추출하는 것이 더욱 바람직하다. 추출 온도는 20℃ 내지 100℃인 것이 바람직하며, 20℃ 내지 50℃인 것이 가장 바람직하나, 이에 한정하지 않는다. 또한, 추출시간은 1 내지 48시간이 바람직하며, 2 내지 10시간이 더욱 바람직하고, 2 내지 5시간이 가장 바람직하나, 이에 한정하지 않는다. 아울러 추출 횟수는 1 내지 5회인 것이 바람직하며, 3 내지 4회 반복 추출하는 것이 더욱 바람직하고, 3회인 것이 가장 바람직하나, 이에 한정되는 것은 아니다.
In the production method of the present invention, it is preferable to use water, an alcohol or a mixture thereof in the extraction solvent in the step 1), but it is most preferable to use water vapor. As the alcohol, C 1 to C 2 lower alcohols are preferably used. As the extraction method, it is preferable to use shaking extraction, Soxhelt extraction, reflux extraction, or steam distillation extraction method, and it is most preferable to use steam distillation extraction method. It is preferable that the extraction solvent is added by 1 to 10 times the amount of the dried white or woody wood, and it is more preferable that the extraction solvent is added by 2 to 3 times. The extraction temperature is preferably 20 ° C to 100 ° C, and most preferably 20 ° C to 50 ° C, but is not limited thereto. The extraction time is preferably 1 to 48 hours, more preferably 2 to 10 hours, most preferably 2 to 5 hours, but is not limited thereto. The number of times of extraction is preferably 1 to 5 times, more preferably 3 to 4 times, more preferably 3 times, but is not limited thereto.
본 발명의 구체적인 실시예에서 본 발명자들은 편백나무 추출물 및 황칠나무 추출물을 각각 제조한 후, 상기 추출물을 혼합한 다음 아토피 피부염 환자에게 도포한 결과, 편백나무 수증기 추출물 및 황칠나무 수증기 추출물을 1:1로 혼합한 혼합물이 아토피 피부염의 각 증상들에 대하여 유의적인 효과를 나타내며, 특히 가려움증 개선으로 인한 긁는 횟수와 육인으로 관찰된 홍반, 발진이 다른 실험군과 비교하여 현저히 우수함을 확인하였다(표 1 참조).In a specific example of the present invention, the inventors of the present invention prepared each of the extracts of P. japonicus and P. japonicus, respectively, and then applied the extracts to patients suffering from atopic dermatitis. As a result, (Table 1). The results are shown in Table 1. [Table 1] < EMI ID = 13.1 > < tb > < TABLE > Id = Table 2 Columns = 2 < tb > .
따라서, 본 발명의 편백나무 수증기 추출물 및 황백나무 수증기 추출물을 포함하는 조성물은 아토피 환자를 대상으로한 피부 도포실험에서 유의적인 아토피 피부염 개선효과를 나타내므로, 상기 조성물은 아토피 피부염 개선용 화장료 조성물의 유효성분으로 유용하게 사용될 수 있다.
Accordingly, the composition of the present invention comprising a water extract of Clostel wood and a water-white steam extract of the present invention exhibits a significant atopic dermatitis-improving effect in skin application tests for patients with atopic dermatitis, May be useful as an ingredient.
본 발명에 따른 화장료 조성물은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 스프레이 및 이들의 혼합물로 구성된 군으로부터 선택되는 제형을 가질 수 있다.The cosmetic composition according to the present invention may be in the form of a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, ≪ / RTI >
본 발명에 따른 화장료 조성물은 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 비누, 계면활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 본 발명의 조성물이 화장료 조성물로 사용될 때에는 화장수, 에멀젼, 크림, 에센스, 젤, 팩 및 클렌징크림으로부터 선택되는 기초 화장료; 화운데이션 등의 메이크업 화장료로 구성되는 군으로부터 선택되는 제형으로 제조될 수 있다.The cosmetic composition according to the present invention may be prepared into any of the formulations conventionally produced in the art, for example, a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, a soap, But are not limited to, cleansing, oil, powder foundation, emulsion foundation, wax foundation, and spray. More particularly, when the composition of the present invention is used as a cosmetic composition, a cosmetic preparation is selected from cosmetic lotion, emulsion, cream, essence, gel, pack and cleansing cream; Makeup cosmetics such as foundation, and the like.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, an animal oil, vegetable oil, wax, paraffin, starch, tracant, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as the carrier component .
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, / Propane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, , 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid esters.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소 결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.In the case where the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Cellulose, aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is an interfacial active agent-containing cleansing, the carrier component is selected from aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, fatty acid amide Ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives or ethoxylated glycerol fatty acid esters.
또한 본 발명의 화장료 조성물은 각각의 제형에 상기 기재한 성분들 이외에 일반 피부화장료에 배합되는 유분, 물, 계면활성제, 보습제, 저급알코올, 증점제, 킬레이트제, 색소, 방부제, 또는 향료 등을 필요에 따라 적절히 배합하여 사용할 수 있다.In addition, the cosmetic composition of the present invention may further contain, in addition to the components described above, oil, water, a surfactant, a moisturizer, a lower alcohol, a thickener, a chelating agent, a coloring agent, an antiseptic, And can be appropriately used in combination.
예컨대, 유연화장수는 본 발명에 따른 조성물 이외에 다가알콜류(프로필렌글리콜, 글리세린 등) 1∼10 중량% 및 계면활성제(폴리에틸렌올레일에테르, 폴리옥시에틸렌 경화피마자유 등) 0.05∼2 중량%를 함유하도록 제조할 수 있다. 또한, 영양화장수 및 영양크림은 본 발명에 따른 조성물 이외에 오일류(스쿠알란, 바셀린, 옥틸도데칸올 등) 5∼20 중량% 및 왁스성분(세탄올, 스테아릴알콜, 밀납 등) 3∼15 중량%를 함유하도록 제조할 수 있으며, 에센스는 본 발명에 따른 조성물 이외에 글리세린, 프로필렌글리콜 등의 다가알콜류 5∼30 중량%를 함유하여 제조할 수 있다. 마사지 크림은 본 발명에 따른 조성물 이외에 유동파라핀, 바셀린, 이소노닐이소노나노에이트 등의 오일 30∼70 중량%를 함유하여 제조되며, 팩은 본 발명에 따른 조성물 이외에 폴리비닐알콜 5∼20 중량%를 함유하는 필 오프(peel off) 팩 또는 일반유화형 화장료에 본 발명에 따른 조성물 이외에 카올린, 탈크, 산화아연, 이산화티탄 등의 안료가 5∼30 중량% 함유된 워시오프(wash off) 팩으로 제조할 수 있다.
For example, besides the composition according to the present invention, the number of softening agents may be selected so that 1 to 10 wt% of polyhydric alcohols (propylene glycol, glycerin, etc.) and 0.05 to 2 wt% of a surfactant (polyethylene oleyl ether, polyoxyethylene hardened castor oil, etc.) Can be manufactured. The nutritional lotion and nutritional cream may contain 5 to 20% by weight of oils (squalane, petrolatum, octyldodecanol, etc.) and 3 to 15% by weight of wax components (cetanol, stearyl alcohol, And the essence may be prepared by adding 5 to 30% by weight of polyhydric alcohols such as glycerin and propylene glycol in addition to the composition according to the present invention. In addition to the composition according to the present invention, the massage cream contains 30 to 70% by weight of an oil such as liquid paraffin, petrolatum, isononylisononanoate and the like, and the pack contains 5 to 20% by weight of polyvinyl alcohol, A wash off pack containing 5 to 30% by weight of pigment such as kaolin, talc, zinc oxide, titanium dioxide, etc. in addition to the composition according to the present invention in a peel off pack or general emulsion type cosmetic containing Can be manufactured.
아울러, 본 발명은 편백나무 추출물 및 황칠나무 추출물을 유효성분으로 함유하는 아토피 피부염 예방 및 개선용 피부 외용제를 제공한다.In addition, the present invention provides an external preparation for skin for prevention and improvement of atopic dermatitis, which contains an extract of Ungermanychus cinnabarstus and a extract of Hwangchujang tree as an active ingredient.
본 발명의 편백나무 수증기 추출물 및 황백나무 수증기 추출물을 포함하는 조성물은 아토피 환자를 대상으로한 피부 도포실험에서 유의적인 아토피 피부염 개선효과를 나타내므로, 상기 조성물은 아토피 피부염 예방 및 개선용 피부 외용제의 유효성분으로 유용하게 사용될 수 있다.
The composition of the present invention comprising a water extract of Clostel wood and a water-white steam extract of the present invention exhibits a significant atopic dermatitis-improving effect in skin application tests for patients with atopic dermatitis, and thus the composition is effective for the prevention and improvement of atopic dermatitis May be useful as an ingredient.
아토피 피부염 예방 및 개선을 위하여, 적합한 외용제형을 선택하는 것이 중요하다. 따라서, 본 발명의 조성물이 환부에 효과적으로 적용될 수 있도록 연고제로 제조할 수 있다. 상기 연고제는 본 발명의 혼합물을 무기물질과 배합한 다음, 이를 지용성 기제로 코팅하여 제조한다. 상기 무기물질은 항균성, 소염효과, 표피재생 효과 등이 우수한 소재를 사용하는 것이 바람직하고, 이들의 구체적인 예로는 산화아연, 탄산아연, 산화철 등이 있다. 또한, 수용성 물질인 본 발명의 조성물을 안전하게 함침 할 수 있는 세라믹 담체를 추가로 사용하는 것이 바람직하다. 상기 세라믹 담체로는 제올라이트, 활석, 석고, 모려분 및 이들의 혼합물이 바람직하게 사용된다. 이러한 세라믹 담체는 수용성 성분의 함침성이 우수하여 피부에 수용성 성분의 공급을 원활히 할 수 있다.
For prevention and improvement of atopic dermatitis, it is important to select an appropriate external preparation type. Accordingly, the composition of the present invention can be manufactured with an ointment agent so that it can be effectively applied to the affected part. The ointment agent is prepared by compounding the mixture of the present invention with an inorganic material and coating it with a liposoluble base. The inorganic material is preferably a material having excellent antimicrobial activity, anti-inflammatory effect, epidermal regeneration effect, etc. Specific examples thereof include zinc oxide, zinc carbonate, iron oxide and the like. Further, it is preferable to further use a ceramic carrier capable of safely impregnating the composition of the present invention, which is a water-soluble substance. As the ceramic carrier, zeolite, talc, gypsum, mortar and mixtures thereof are preferably used. Such a ceramic carrier is excellent in the impregnation property of the water-soluble component, so that the water-soluble component can be smoothly supplied to the skin.
이하 본 발명을 실시예, 실험예 및 제조예에 의해 상세히 설명한다.Hereinafter, the present invention will be described in detail with reference to Examples, Experimental Examples and Preparation Examples.
단, 하기 실시예, 실험예 및 제조예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예, 실험예 및 제조예에 한정되는 것은 아니다.
However, the following Examples, Experimental Examples and Preparation Examples are merely illustrative of the present invention, and the content of the present invention is not limited to the following Examples, Experimental Examples and Production Examples.
<실시예 1> 편백나무 추출물의 제조Example 1: Preparation of an extract of Prunus mume
<1-1> 편백나무 에탄올 추출물의 제조≪ 1-1 > Preparation of Ethanol Extract of White Oak
편백나무를 채취하여 이물질 및 불순물이 완전히 제거되도록 깨끗이 세척한 후 20 내지 35℃의 온도가 유지되는 음지에서 건조하고, 121℃의 온도에서 30분 동안 멸균시킨 후 냉각시켰다. 그 다음 상기 멸균한 잎 및 가지의 입자 크기가 0.5mm 이하가 되도록 분쇄한 후, 상기 편백나무 분말 60g을 에탄올 1ℓ에 침지한 후 가열하여 편백나무 에탄올 추출물을 제조하였다.The cottonwood was picked and cleaned to remove the foreign matter and impurities completely, and then dried in a shade maintained at a temperature of 20 to 35 DEG C, sterilized at a temperature of 121 DEG C for 30 minutes, and cooled. Then, the granules were pulverized so that the particle size of the sterilized leaves and branches was 0.5 mm or less. Then, 60 g of the granular white powder was immersed in 1 liter of ethanol and heated to prepare an albino ethanol extract.
<1-2> 편백나무 수증기 추출물의 제조<1-2> Preparation of water vapor extract
편백나무를 채취하여 이물질 및 불순물이 완전히 제거되도록 깨끗이 세척한 후 20 내지 35℃의 온도가 유지되는 음지에서 건조하고, 121℃의 온도에서 30분 동안 멸균시킨 후 냉각시켰다. 그 다음 상기 멸균한 잎 및 가지의 입자 크기가 0.5mm 이하가 되도록 분쇄한 후, 상기 편백나무 분말 60g을 증류수 1ℓ에 침지하고 가열한 후 증발되는 수증기를 모아 편백나무 수증기 추출물을 제조하였다.
The cottonwood was picked and cleaned to remove the foreign matter and impurities completely, and then dried in a shade maintained at a temperature of 20 to 35 DEG C, sterilized at a temperature of 121 DEG C for 30 minutes, and cooled. Then, the particles of the sterilized leaves and branches were pulverized to have a particle size of 0.5 mm or less. Then, 60 g of the white powdery wood powder was immersed in 1 L of distilled water, heated, and the water vapor evaporated was collected.
<실시예 2> 황칠나무 추출물의 제조<Example 2> Preparation of extracts
<2-1> 황칠나무 에탄올 추출물의 제조<2-1> Preparation of Ethanol Extract of Yellow Grass Tree
황칠나무를 채취하여 이물질 및 불순물이 완전히 제거되도록 깨끗이 세척한 후 20 내지 35℃의 온도가 유지되는 음지에서 건조하고, 121℃의 온도에서 30분 동안 멸균시킨 후 냉각시켰다. 그 다음 상기 멸균한 잎 및 가지의 입자 크기가 0.5mm 이하가 되도록 분쇄한 후, 상기 황칠나무 분말 60g을 에탄올에 침지한 후 가열하여 황칠나무 에탄올 추출물을 제조하였다.
The woods were picked and washed thoroughly to remove impurities and impurities completely, then dried in a shade maintained at a temperature of 20 to 35 ° C, sterilized at a temperature of 121 ° C for 30 minutes, and cooled. Then, the powder was pulverized so that the particle size of the sterilized leaves and branches was 0.5 mm or less. Then, 60 g of the powdered wood powder was immersed in ethanol and heated to prepare an ethanol extract of Yellow Hut tree.
<2-2> 황칠나무 수증기 추출물의 제조<2-2> Preparation of water vapor extract
황칠나무를 채취하여 이물질 및 불순물이 완전히 제거되도록 깨끗이 세척한 후 20 내지 35℃의 온도가 유지되는 음지에서 건조하고, 121℃의 온도에서 30분 동안 멸균시킨 후 냉각시켰다. 그 다음 상기 멸균한 잎 및 가지의 입자 크기가 0.5mm 이하가 되도록 분쇄한 후, 상기 황칠나무 분말 60g을 증류수 1ℓ에 침지하고 가열한 후 증발되는 수증기를 모아 황칠나무 수증기 추출물을 제조하였다.
The woods were picked and washed thoroughly to remove impurities and impurities completely, then dried in a shade maintained at a temperature of 20 to 35 ° C, sterilized at a temperature of 121 ° C for 30 minutes, and cooled. Then, the powder was pulverized so that the particle size of the sterilized leaves and branches was 0.5 mm or less. Then 60 g of the powdered wood powder was immersed in 1 liter of distilled water and heated. Then, the water vapor evaporated was collected to prepare a steamed watermelon extract.
<실시예 3> 편백나무 및 황칠나무 혼합 추출물의 제조≪ Example 3 > Preparation of Mixed Extracts of Polygonatum and Wiltwood
<3-1> 편백나무 및 황칠나무 에탄올 추출물의 혼합물의 제조≪ 3-1 > Preparation of a mixture of an ethanol extract of Wanbai and Huaxia tree
상기 <실시예 1> 및 <실시예 2>에서 제조한 편백나무 에탄올 추출물 및 황칠나무 에탄올 추출물을 각각 100 ㎖ 혼합하여 편백나무 및 황칠나무 에탄올 추출물의 혼합물을 제조하였다.
100 ml of each of the extracts of the whitening wood and ethanol extract of the whitening woods prepared in Example 1 and Example 2 was mixed to prepare a mixture of an extract of Chenille wood and the extract of Huangchu tree.
<3-2> 편백나무 및 황칠나무 수증기 추출물의 3:1 혼합물의 제조<3-2> Preparation of 3: 1 Mixture of Steam Extracts of Polyunsaturated Trees and Yellowtail Trees
상기 <실시예 1> 및 <실시예 2>에서 제조한 편백나무 수증기 추출물 150 ㎖ 및 황칠나무 수증기 추출물 50 ㎖ 혼합하여 편백나무 및 황칠나무 수증기 추출물 3:1 혼합물을 제조하였다.
The mixture of 150 ml of the white wool water vapor extract and 50 ml of the water extract of Huchilchia tree prepared in Examples 1 and 2 were mixed to prepare a 3: 1 mixture of white walnut tree and Huaxia tree water vapor extract.
<3-3> 편백나무 및 황칠나무 수증기 추출물의 2:1 혼합물의 제조 ≪ 3-3 > Preparation of 2: 1 mixture of water-white and woody water extracts
상기 <실시예 1> 및 <실시예 2>에서 제조한 편백나무 수증기 추출물 133 ㎖ 및 황칠나무 수증기 추출물 67 ㎖ 혼합하여 편백나무 및 황칠나무 수증기 추출물 2:1 혼합물을 제조하였다.
133 ml of the water extract of unshrubby trees and 67 ml of the water extract of Hwangcholguk tree prepared in Example 1 and Example 2 were mixed to prepare a 2: 1 mixture of Waxy wood and Huaxia tree water vapor extract.
<3-4> 편백나무 및 황칠나무 수증기 추출물의 1:1 혼합물의 제조 <3-4> Preparation of 1: 1 Mixture of Steam Extracts from Prunus mume
상기 <실시예 1> 및 <실시예 2>에서 제조한 편백나무 수증기 추출물 100 ㎖ 및 황칠나무 수증기 추출물 100 ㎖ 혼합하여 편백나무 및 황칠나무 수증기 추출물 1:1 혼합물을 제조하였다.
The mixture of 100 ml of the water extract of Clark's wood vinegar and 100 ml of the water vapor extract of Hwangcholgak tree prepared in Example 1 and Example 2 were mixed to prepare a 1: 1 mixture of Waxy wood and Huaxia tree water vapor extract.
<실험예 1> 편백나무 및 황칠나무 추출물의 항아토피 효과 확인<Experimental Example 1> Confirmation of anti-atopic effect of extracts
상기 <실시예 3>에서 제조한 편백나무 추출물 및 황칠나무 추출물을 포함하는 혼합물의 아토피 피부염 개선 효과를 확인하였다.The effect of improving the atopic dermatitis of the mixture containing the extract of Wakaba tree and the extract of Echinochloa crusa prepared in Example 3 was confirmed.
구체적으로, 아토피 피부염 환자로 진단받은 환자 중, 6개월 이내에 아토피 피부염 치료를 위해 국소 및 전신 스테로이드, 면역 조절 및 억제제, 항히스타민제나 이에 준하는 치료를 받은 경험이 있는 환자를 제외한 환자 30명은 선정한 후, 상기 실시예 <3-1> 내지 <3-4>에서 제조한 편백나무 추출물 및 황칠나무 추출물을 포함하는 혼합물을 상기 선정된 환자에게 매일 1회, 4주간 도포하였다. 그런 다음 가려움 등의 증상 완화에 대한 문진 평가와 육안적으로 확인 가능한 홍반, 발진 등을 처리전과 비교하였으며, 5점 만족 척도로 평가하였다.
Specifically, among patients diagnosed with atopic dermatitis, 30 patients were selected for treatment of atopic dermatitis within 6 months except for those patients who had received topical and systemic steroids, immunomodulators and inhibitors, antihistamines or similar treatments, The mixture containing the extract of Wakaba tree and the extract of Echinochloa crus-galli prepared in Examples <3-1> to <3-4> was applied to the selected patients once a day for four weeks. Then, we evaluated the results of the questionnaire about the symptom relief such as itching and the grossly visible erythema and rash before the treatment, and evaluated it with the 5 point satisfaction scale.
그 결과, 상기 표 1에 나타낸 바와 같이, 문진 결과, 편백나무 수증기 추출물 및 황칠나무 수증기 추출물을 1:1로 혼합한 혼합물이 아토피 피부염의 각 증상들에 대하여 유의적인 효과를 갖는다고 응답하였으며, 특히 가려움증 개선으로 인한 긁는 횟수와 육인으로 관찰된 홍반, 발진이 다른 실험군과 비교하여 현저히 우수함을 확인하였다(표 1).As a result, as shown in Table 1, a mixture of 1: 1 mixture of the extract of Waxy wood steam and the extract of Watermelon wood steam showed a significant effect on each symptom of atopic dermatitis The number of scratches due to the improvement of itching and the erythema and rash observed by the human eye were significantly superior to those of the other experimental groups (Table 1).
결론적으로, 편백나무 수증기 추출물 및 황칠나무 수증기 추출물을 1:1로 혼합한 혼합물은 아토피 피부염 화장료 조성물로 유용하게 사용될 수 있음을 확인하였다.
In conclusion, it has been confirmed that a mixture of a water vapor extract of Waxy wood and a water vapor extract of Hwangchu tree at 1: 1 can be useful as a cosmetic composition for atopic dermatitis.
<제조예 1> 화장수의 제조Production Example 1 Production of Lotion
실시예 <3-4>에서 제조한 혼합물 5.0 중량%, 글리세린 5.0 중량%, 1,3-부틸렌글라이콜 5.0 중량%, 히아루론산 0.2 중량%, 폴리옥시에틸렌 경화피마자유 0.15 중량%, 에탄올 5.0 중량%, 방부제 0.1중량%, 적정량의 향료 및 잔량의 정제수를 혼합하여 화장수를 제조하였다.
5.0 wt% of the mixture prepared in Example <3-4>, 5.0 wt% of glycerin, 5.0 wt% of 1,3-butylene glycol, 0.2 wt% of hyaluronic acid, 0.15 wt% of polyoxyethylene hydrogenated castor oil, 5.0 wt %, A preservative 0.1% by weight, a proper amount of perfume, and a remaining amount of purified water were mixed to prepare a lotion.
<제조예 2> 에센스의 제조≪ Preparation Example 2 > Preparation of essence
실시예 <3-4>에서 제조한 혼합물 5.0 중량%, 세토스테아릴알코올 2.0중량%, 자가유화형 모노스테아린산 1.5중량%, 디메치콘 3.0중량%, 모노스테아린산소르비탄 0.5중량%, 스테아린산 1.0중량%, 미네랄 오일 5.0중량%, 호호바오일 2.0중량%, 모노스테아린산폴리에틸렌글리콜 7.0중량%, 글리세린 3.0중량%, 1,3-부틸렌글라이콜 3.0중량%, 카보머 0.15중량%, 트리에탄올아민 0.2중량%, 적정량의 방부제, 향료와 잔량의 정제수를 혼합하여 에센스를 제조하였다.
5.0 wt% of the mixture prepared in Example <3-4>, 2.0 wt% of cetostearyl alcohol, 1.5 wt% of self emulsifying monostearic acid, 3.0 wt% of dimethicone, 0.5 wt% of monostearic acid sorbitan, 1.0 wt% 5.0 wt% of mineral oil, 2.0 wt% of jojoba oil, 7.0 wt% of monostearic acid polyethylene glycol, 3.0 wt% of glycerin, 3.0 wt% of 1,3-butylene glycol, 0.15 wt% of carbomer, 0.2 wt% of triethanolamine, A proper amount of preservative, fragrance and remaining amount of purified water were mixed to prepare an essence.
<제조예 3> 로션의 제조≪ Preparation Example 3 > Production of lotion
실시예 <3-4>에서 제조한 혼합물 5.0 중량%, 세토스테아릴알코올 2.0중량%, 자가유화형 모노스테아린산 1.5중량%, 디메치콘 3.0중량%, 모노스테아린산소르비탄 0.5중량%, 스테아린산 1.0중량%, 미네랄 오일 5.0중량%, 호호바오일 2.0중량%, 모노스테아린산폴리에틸렌글리콜 7.0중량%, 글리세린 3.0중량%, 1,3-부틸렌글라이콜 5.0중량%, 카보머 0.2중량%, 트리에탄올아민 0.3중량%, 적정량의 방부제, 향료와 잔량의 정제수를 혼합하여 로션을 제조하였다.
5.0 wt% of the mixture prepared in Example <3-4>, 2.0 wt% of cetostearyl alcohol, 1.5 wt% of self emulsifying monostearic acid, 3.0 wt% of dimethicone, 0.5 wt% of monostearic acid sorbitan, 1.0 wt% 5.0 wt% of mineral oil, 2.0 wt% of jojoba oil, 7.0 wt% of monostearic acid polyethylene glycol, 3.0 wt% of glycerin, 5.0 wt% of 1,3-butyleneglycol, 0.2 wt% of carbomer, 0.3 wt% of triethanolamine, A lotion was prepared by mixing a proper amount of preservative, fragrance and remaining amount of purified water.
<제조예 4> 크림의 제조≪ Preparation Example 4 > Preparation of cream
실시예 <3-4>에서 제조한 혼합물 7.0 중량%, 세토스테아릴알코올 4.0중량%, 자가유화형 모노스테아린산 3.0중량%, 디메치콘 5.0중량%, 모노스테아린산소르비탄 2.0중량%, 스테아린산 3.0중량%, 미네랄 오일 5.0중량%, 호호바오일 4.0중량%, 모노스테아린산폴리에틸렌글리콜 7.0중량%, 글리세린 5.0중량%, 1,3-부틸렌글라이콜 5.0중량%, 카보머 0.3중량%, 트리에탄올아민 0.4중량%, 적정량의 방부제, 향료와 잔량의 정제수를 혼합하여 크림을 제조하였다.
7.0 weight% of the mixture prepared in Example <3-4>, 4.0 weight% of cetostearyl alcohol, 3.0 weight% of self emulsifying monostearic acid, 5.0 weight% of dimethicone, 2.0 weight% of monostearic acid sorbitan, 3.0 weight% 5.0 wt% of mineral oil, 4.0 wt% of jojoba oil, 7.0 wt% of monostearic acid polyethylene glycol, 5.0 wt% of glycerin, 5.0 wt% of 1,3-butylene glycol, 0.3 wt% of carbomer, 0.4 wt% of triethanolamine, A cream was prepared by mixing a proper amount of preservative, perfume and remaining amount of purified water.
Claims (9)
A cosmetic composition for improving atopic dermatitis containing an extract of Chamaecyparis obtusa and a extract of Dendropanax morbifera as an active ingredient.
The cosmetic composition for improving atopic dermatitis according to claim 1, wherein the extract of Wakabayashi tree and the extract of Wakayama tree are extracted with water vapor.
[Claim 3] The cosmetic composition for improving atopic dermatitis according to claim 1, wherein the extract is selected from the group consisting of Cryptomeria japonica extract and Horticultural extract.
The cosmetic composition for improving atopic dermatitis according to claim 1, wherein the cosmetic composition enhances the skin moisture content, stabilizes the pH of the skin, and reduces the amount of transdermal moisture evaporation.
The cosmetic composition of claim 1, wherein the cosmetic composition is a solution, suspension, emulsion, paste, gel, cream, lotion, powder, soap, surfactant-containing cleansing, oil, powder foundation, emulsion foundation, wax foundation, And at least one compound selected from the group consisting of:
A skin external preparation for prevention and improvement of atopic dermatitis, which contains an extract of Chamaecyparis obtusa and an extract of Hokkaido tree as an active ingredient.
The external preparation for skin as set forth in claim 6, wherein the extract of Wakabayashi tree and the extract of Wakayama tree is extracted with water vapor.
The external preparation for skin as set forth in claim 6, wherein the extract is selected from the group consisting of wheat germ extract and woodworm extract.
[Claim 7] The external preparation for skin prevention and improvement according to claim 6, wherein the external preparation for skin improves the moisture content of the skin, stabilizes the pH of the skin, and reduces the amount of percutaneous water evaporation.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160022558A KR20170100245A (en) | 2016-02-25 | 2016-02-25 | Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160022558A KR20170100245A (en) | 2016-02-25 | 2016-02-25 | Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020180002273A Division KR20180006475A (en) | 2018-01-08 | 2018-01-08 | Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20170100245A true KR20170100245A (en) | 2017-09-04 |
Family
ID=59924292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020160022558A Ceased KR20170100245A (en) | 2016-02-25 | 2016-02-25 | Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20170100245A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190041724A (en) | 2017-10-13 | 2019-04-23 | 김의준 | Cosmetic composition comprising hippophae rhamnoides seed oil extract |
| KR20190046096A (en) | 2017-10-25 | 2019-05-07 | (주)예스킨 | Composition for treating atopic dermatitis |
| KR20220091239A (en) | 2020-12-23 | 2022-06-30 | 전소정 | Composition for preventing and alleviating redness and atopy using natural materials, and cosmetics containing the same |
-
2016
- 2016-02-25 KR KR1020160022558A patent/KR20170100245A/en not_active Ceased
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20190041724A (en) | 2017-10-13 | 2019-04-23 | 김의준 | Cosmetic composition comprising hippophae rhamnoides seed oil extract |
| KR20190046096A (en) | 2017-10-25 | 2019-05-07 | (주)예스킨 | Composition for treating atopic dermatitis |
| KR20220091239A (en) | 2020-12-23 | 2022-06-30 | 전소정 | Composition for preventing and alleviating redness and atopy using natural materials, and cosmetics containing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101618162B1 (en) | Natural perfume composition comprising functional natural plant extract mixtures for health | |
| KR101516002B1 (en) | Cosmetic composite for alleviating atopic dermatitis and the manufacturing for the same | |
| KR101471818B1 (en) | Cosmetic composition for alleviating dermatitis and skin irritation | |
| JP2003113013A (en) | Plant antibacterial preservative | |
| KR101765832B1 (en) | Essential Oils with antibacterial substance | |
| CN105055244A (en) | Organic natural plant preservative | |
| KR101767979B1 (en) | Composition Containing Hinoki Cypress Extract | |
| KR101209189B1 (en) | herbal soap with antibacteria function | |
| KR102366247B1 (en) | Wet wipe composition and its manufacturing method | |
| KR20180078564A (en) | Natural cosmetic formulation with excellent effect for skin soothing and moisturizing maintenance | |
| KR101780863B1 (en) | Cosmetic Composion for Acne Improvement Containing Butanol Fraction of Red Ginseng Ethanol Extract | |
| KR20200053815A (en) | A cosmetic composition for improving skin containing a peptide | |
| KR102166300B1 (en) | The Beauty art-soap of The composition of beauty art-soap having multi-fuction and the method of preparing the beauty art-soap of multi-function using it. | |
| US20150086522A1 (en) | Formulation containing herb infused aloe | |
| KR20170100245A (en) | Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients | |
| KR20120009554A (en) | Cosmetic composition containing herbal extracts having antioxidant and anti-allergic effects | |
| KR20170058546A (en) | Cosmetic Composition for Reducing Skin Wrinkle | |
| KR20130089045A (en) | Composition containing bee venom and propolis for preventing or treating acne | |
| RU2118152C1 (en) | Cosmetic cream for prophylaxis of skin mycosis "rada-plus" | |
| KR101969475B1 (en) | Cosmetic compositions for improving skin comprising mixed plant extract with Cirsium japonicum as effective ingradients | |
| KR20170041149A (en) | Composition for improving atopic skin | |
| KR102721531B1 (en) | Mist Composition comprising Sasa borealis extracts | |
| KR101869763B1 (en) | Composition for preventing and curing dermatophytosis | |
| KR101629863B1 (en) | Cosmetic composition for moisturizing and anti-aging containing extracts of Viscum album, Chamaecyparis Obtusa, Quercus Robur and Camellia japonica Linne | |
| KR20180006475A (en) | Cosmetic composition for improving atopic dermatitis comprising steam extracts of Chamaecyparis obtusa and Dendropanax morbifera as active ingredients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160225 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170703 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20171208 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20170703 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| A107 | Divisional application of patent | ||
| PA0107 | Divisional application |
Comment text: Divisional Application of Patent Patent event date: 20180108 Patent event code: PA01071R01D |